Arohi Pharma Distributors Private Limited
Founded in 2017 and headquartered in West Bengal, India.
2017 | Howrah, West Bengal (India) | Active
Arohi Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.88 M
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 124.61%
- Ebitda -47.59%
- Net Worth 0.57%
- Total Assets 1.58%
About Arohi Pharma Distributors
Arohi Pharma Distributors Private Limited (APDPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 August 2017 (Seven years and six months 5 days old ). Its registered office is in Howrah, West Bengal, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.88 M, as per Ministry of Corporate Affairs (MCA) records.
Pradeep Das and Madhu Das serve as directors at the Company.
Company Details
- Location
Howrah, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999WB2017PTC222461
- Company No.
222461
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Aug 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Business Services
Who are the key members and board of directors at Arohi Pharma Distributors?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Das  | Director | 25-Aug-2017 | Current |
| Madhu Das | Director | 25-Aug-2017 | Current |
Financial Performance of Arohi Pharma Distributors.
Arohi Pharma Distributors Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 124.61% increase in profit. The company's net worth moved up by a moderate rise of 0.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arohi Pharma Distributors?
Unlock access to Arohi Pharma Distributors's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arohi Pharma Distributors?
Unlock and access historical data on people associated with Arohi Pharma Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arohi Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arohi Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.